Method for treating cancer
US12168014B2 · kind B2 · utility
0Cited by
19References
62Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 20, 2020 |
| Grant date | Dec 17, 2024 |
| Priority date | — |
| Expiry date | Feb 4, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pharmaceutical compositions comprising inhibitor(s) of human histone methyltransferase EZH2, and methods of cancer therapy using the EZH2 inhibitor(s).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.